01 1Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.
01 1DAPTOMYCIN
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2018-01-04
Pay. Date : 2017-09-20
DMF Number : 29859
Submission : 2015-09-17
Status : Active
Type : II
20
Livzon Group Fuzhou Fuxing Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is DAPTOMYCIN, with a corresponding US DMF Number 29859.
Remarkably, this DMF maintains an Active status since its submission on September 17, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 04, 2018, and payment made on September 20, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II
